This is a preview of subscription content, log in via an institution to check access.
Reference
Scottish Medicines Consortium. SMC advice: aripiprazole (Abilify); certolizumab pegol (Cimzia); dolutegravir (Tivicay); infliximab (Remicade). Internet Document : 15 May 2014. Available from: URL: http://www.scottishmedicines.org.uk
Rights and permissions
About this article
Cite this article
SMC says yes to dolutegravir, aripiprazole, certolizumab pegol. PharmacoEcon Outcomes News 703, 10 (2014). https://doi.org/10.1007/s40274-014-1271-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1271-7